AI assistant
Sending…
VERACYTE, INC. — Director's Dealing 2020
May 13, 2020
31551_dirs_2020-05-13_7f40a36d-48b5-40ee-92a3-bf857199ecb4.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: VERACYTE, INC. (VCYT)
CIK: 0001384101
Period of Report: 2020-05-11
Reporting Person: Kennedy Giulia C (Chief Scientific & Med Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2020-05-11 | Common Stock | A | 300 | — | Acquired | 81574 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2020-05-11 | Stock Option (right to buy) | $26.55 | A | 1750 | Acquired | 2030-05-10 | Common Stock (1750.0) | Direct |
Footnotes
F1: Restricted stock units awarded on May 11, 2020 vest 18 months from May 1, 2020 subject to continuing employment of the Reporting Person on the vesting date.
F2: The stock options awarded on May 11, 2020 vest 18 months from May 1, 2020 subject to continuing employment of the Reporting Person on the vesting date.
More from VERACYTE, INC.
Interim / Quarterly Report
2026
May 6
Proxy Solicitation & Information Statement
2026
Apr 22
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 2
Director's Dealing
2026
Mar 2
Director's Dealing
2026
Mar 2
Director's Dealing
2026
Mar 2
Director's Dealing
2026
Mar 2
Annual Report
2026
Feb 26
Regulatory Filings
2026
Feb 25